Role of RANKL-RANK/osteoprotegerin pathway in cardiovascular and bone disease associated with HIV infection.
about
Denosumab: targeting the RANKL pathway to treat rheumatoid arthritis.Higher Levels of Osteoprotegerin and Immune Activation/Immunosenescence Markers Are Correlated with Concomitant Bone and Endovascular Damage in HIV-Suppressed Patients.Beyond Antibodies: B Cells and the OPG/RANK-RANKL Pathway in Health, Non-HIV Disease and HIV-Induced Bone Loss.Changes in plasma RANKL-osteoprotegerin in a Prospective, Randomized Clinical trial of Initial Antiviral Therapy: A5260s.
P2860
Role of RANKL-RANK/osteoprotegerin pathway in cardiovascular and bone disease associated with HIV infection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of RANKL-RANK/osteoproteg ...... associated with HIV infection.
@en
Role of RANKL-RANK/osteoproteg ...... associated with HIV infection.
@nl
type
label
Role of RANKL-RANK/osteoproteg ...... associated with HIV infection.
@en
Role of RANKL-RANK/osteoproteg ...... associated with HIV infection.
@nl
prefLabel
Role of RANKL-RANK/osteoproteg ...... associated with HIV infection.
@en
Role of RANKL-RANK/osteoproteg ...... associated with HIV infection.
@nl
P2093
P2860
P1433
P1476
Role of RANKL-RANK/osteoproteg ...... associated with HIV infection.
@en
P2093
Judith S Currier
Otto O Yang
Todd T Brown
P2860
P304
P577
2014-07-01T00:00:00Z